Journal Image
Recent Patents on Anti-Infective Drug Discovery
ISSN (Print): 1574-891X
ISSN (Online): 2212-4071
DOI: 10.2174/157489112803521922

Novel Antimicrobial Agents Against Multi-drug-resistant Gram-negative Bacteria: An Overview

Author(s): George Karras, Venetia Giannakaki, Vasilios Kotsis and Spiros Miyakis
Pages 175-181 (7)
No novel antimicrobial agents against multi-drug-resistant Gram-negative bacteria have been available to daily clinical practice during the last 5 years. On the other hand, resistance rates and mechanisms of those pathogens are increasing worldwide. Pan-resistant (against which none of the currently available antibiotics is effective) strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa have been described. Encouraging is the fact that several novel compounds (some of them with mechanisms of action different to those of the antibiotics commercially available) are through the development stages. We summarize the main such compounds that show potential for offering solution to the treatment of Gram-negative multi-resistant bacteria along with the discussion of some patents associated with the topic.
Antimicrobials, multidrug resistance, enterobacteriaceae, Pseudomonas aeruginosa, acinetobacter, carbapenemase, BETA-LACTAMS, BETA-LACTAMASE INHIBITORS, QUINOLONES, TETRACYCLINES
The Academic Suite, Level 8, Block C, The Wollongong Hospital, Wollongong NSW 2500, Australia.